Skip to main content
RecallsAboutBlog

Apotex Corp.

Apotex Corp.: 4 recalls listed since March 2026 across FDA.

By year

  • 20264

By agency

  • FDA4

By category

  • Drug4

All recalls (4)

Apotex Paroxetine Extended-Release Tablets

Paroxetine Extended-Release Tablets failed dissolution specifications.

Moderate risk, FDA, , Drug dissolving problem

Apotex Paxil CR, Paroxetine, Extended-Release Tablets

Paxil CR tablets failed dissolution specifications and stability testing acceptance criteria.

Moderate risk, FDA, , Drug dissolving problem

Apotex Desmopressin Nasal Spray

Desmopressin Nasal Spray has defective bottle caps with dislodged or missing liners.

Moderate risk, FDA, , Packaging defect

Apotex Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution

Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution lacks assurance of sterility.

Moderate risk, FDA, , Sterility problem
Embed this list